These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 16230678

  • 1. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
    Lanciano R, Calkins A, Bundy BN, Parham G, Lucci JA, Moore DH, Monk BJ, O'Connor DM.
    J Clin Oncol; 2005 Nov 20; 23(33):8289-95. PubMed ID: 16230678
    [Abstract] [Full Text] [Related]

  • 2. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
    Kim YS, Shin SS, Nam JH, Kim YT, Kim YM, Kim JH, Choi EK.
    Gynecol Oncol; 2008 Jan 20; 108(1):195-200. PubMed ID: 17963825
    [Abstract] [Full Text] [Related]

  • 3. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
    Stehman FB, Bundy BN, Kucera PR, Deppe G, Reddy S, O'Connor DM.
    Gynecol Oncol; 1997 Aug 20; 66(2):262-7. PubMed ID: 9264574
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA, Tewari KS, Shah A, Brewster WR, Burger RA, Kuo JV, Monk BJ.
    Gynecol Oncol; 2009 Jan 20; 112(1):85-9. PubMed ID: 18977518
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluorouracil in locally advanced cervical cancer.
    Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A, Levin W.
    Gynecol Oncol; 1998 May 20; 69(2):137-45. PubMed ID: 9600821
    [Abstract] [Full Text] [Related]

  • 7. High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
    Lin JC, Ho ES, Jan JS, Yang CH, Liu FS.
    Gynecol Oncol; 1996 Apr 20; 61(1):101-8. PubMed ID: 8626094
    [Abstract] [Full Text] [Related]

  • 8. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
    J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643
    [Abstract] [Full Text] [Related]

  • 9. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
    Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, Rotman M, Gershenson DM, Mutch DG.
    N Engl J Med; 1999 Apr 15; 340(15):1137-43. PubMed ID: 10202164
    [Abstract] [Full Text] [Related]

  • 10. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144.
    Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson AB, Haller DG, Mayer RJ, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS, Leichman CG, Macdonald JS.
    J Clin Oncol; 2006 Aug 01; 24(22):3542-7. PubMed ID: 16877719
    [Abstract] [Full Text] [Related]

  • 11. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications.
    Chen SW, Liang JA, Hung YC, Yeh LS, Chang WC, Lin WC, Yang SN, Lin FJ.
    Int J Radiat Oncol Biol Phys; 2006 Dec 01; 66(5):1370-7. PubMed ID: 16979836
    [Abstract] [Full Text] [Related]

  • 12. Comparison of treatment tolerance and outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy in a prospective randomized trial or with standard treatment.
    Torres MA, Jhingran A, Thames HD, Levenback CF, Bodurka DC, Ramondetta LM, Eifel PJ.
    Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):118-25. PubMed ID: 17869451
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cervical cancer: combined modality therapy.
    Grigsby PW.
    Cancer J; 2001 Jan 01; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combined-modality therapy of locally advanced cervical cancer.
    Rose PG.
    J Clin Oncol; 2003 May 15; 21(10 Suppl):211s-217s. PubMed ID: 12743137
    [Abstract] [Full Text] [Related]

  • 17. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K, Jassem J.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):814-21. PubMed ID: 15465198
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A, Beretta GD, Catalano V, Bertetto O, Barni S, Frontini L, Aitini E, Rota S, Torri V, Floriani I, Italian Group for the Study of Digestive Tract Cancer, Pozzo C, Rimassa L, Mosconi S, Giordani P, Ardizzoia A, Foa P, Rabbi C, Chiara S, Gasparini G, Nardi M, Mansutti M, Arnoldi E, Piazza E, Cortesi E, Pucci F, Silva RR, Sobrero A, Ravaioli A.
    J Natl Cancer Inst; 2007 Apr 18; 99(8):601-7. PubMed ID: 17440161
    [Abstract] [Full Text] [Related]

  • 19. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
    Sakata K, Sakurai H, Suzuki Y, Katoh S, Ohno T, Toita T, Kataoka M, Tanaka E, Kaneyasu Y, Uno T, Harima Y, Nakano T, Japan Radiation Oncology Study Group.
    Acta Oncol; 2008 Apr 18; 47(3):434-41. PubMed ID: 18348003
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
    Rose PG, Ali S, Watkins E, Thigpen JT, Deppe G, Clarke-Pearson DL, Insalaco S, Gynecologic Oncology Group.
    J Clin Oncol; 2007 Jul 01; 25(19):2804-10. PubMed ID: 17502627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.